Omnicell Overview
Omnicell Target Price
Analysts' average 12-month price target for Omnicell is $58.
Get informed when a big investor buys or sells
+ FollowShare Price
$39.41
Average Target Price
$57.50
45.9% upside
45.9% upside2 analysts in the last 4 months
High: $65 | Low: $50
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-31 | KeyBanc | $65 | 64.9% upside |  |
| 2026-07-31 | Wells FargoStan Berenshteyn | $50 | 26.9% upside | |
| 2026-04-29 | Craig-Hallum | $55 | 39.6% upside | |
| 2026-04-28 | KeyBanc | $70 | 77.6% upside | |
| 2026-03-13 | UBS | $60 | 52.2% upside | |
| 2026-02-06 | Piper Sandler | $49 | 24.3% upside | |
| 2026-01-16 | UBS | $53 | 34.5% upside | |
| 2026-01-07 | KeyBanc | $60 | 52.2% upside | |
| 2026-01-05 | Wells Fargo | $52 | 31.9% upside | |
| 2025-08-11 | Piper SandlerJessica Tassan | $55 | 39.6% upside | |
| 2025-05-14 | Wells FargoStan Berenshteyn | $35 |  11.2% downside | |
| 2025-01-13 | Wells FargoStan Berenshteyn | $40 | 1.5% upside | |
| 2024-10-31 | BarclaysStephanie Davis | $58 | 47.2% upside | |
| 2024-08-05 | Piper SandlerSean Wieland | $61 | 54.8% upside | |
| 2024-08-02 | BarclaysStephanie Davis | $39 | 1% downside | |
| 2022-11-18 | J.P. Morgan | $57 | 44.6% upside | |
| 2022-08-08 | Piper SandlerJessica Tassan | $150 | 280.6% upside | |
| 2022-06-16 | Wells FargoStan Berenshteyn | $158 | 300.9% upside | |
| 2022-05-03 | Piper Sandler | $162 | 311.1% upside | |